Acorn Campus, L.L.C.

Acorn Campus, L.L.C. is a venture capital firm based in Santa Clara, California, with additional offices in New York and Shanghai. Founded in 2000, the firm specializes in providing private equity investments to early-stage companies in the technology and life sciences industries, focusing on areas such as communications, wireless, semiconductor, photonics, internet, and networking services. Acorn Campus, L.L.C. typically invests up to $3 million and targets investments in both the United States and China. Led by founder David Tsang, the firm aims to support the growth and development of innovative companies in these sectors through incubation, seed, and early venture investments.

Wu-Fu Chen

Co-Founder & Managing Partner

Hwang Tien-Lai

Business Analysis Venture Partner

David Tsang Ph.D

Co-Founder & Managing Partner

17 past transactions

Waterstone Pharmaceuticals, Inc. is engaged in research, development, and commercialization of drugs for the treatment of liver and gastrointestinal diseases. The company’s products include range of API, intermediates, and antibody drug conjugates. Waterstone Pharmaceuticals, Inc. was founded in 2009 and is based in Wuhan, China with additional offices in Wuhan and Tianmen, China.

Qpixel Technology

Series A in 2004
Qpixel Technology operates as a fabless semiconductor company which provides video compression silicon and software solutions. It develops audio/video compression silicon solutions for digital consumer electronics devices, such as digital cameras and camcorders, set top boxes/PVRs/DVRs and remote monitoring devices, and IP video communications devices. The company's product suite includes standard and high definition codecs with on-chip audio DSP; and design kit, including boards, firmware, and design files for original equipment manufacturer time-to-production. Qpixel Technology, Inc. was founded in 2003 and is headquartered in Cupertino, California with engineering and sales offices in Taiwan and Japan.

Fortinet

Series E in 2004
Fortinet is a provider of network security appliances. Fortinet's portfolio of security gateways, subscription services, and complementary products delivers a high level of network, content, and application security for enterprises of all sizes, managed service providers, and telecommunications carriers, while reducing total cost of ownership and providing a flexible, scalable path for expansion. See an analyst interview of John Maddison, VP Marketing at Fortinet here: https://vimeo.com/129352269

Optovue

Series B in 2007
Optovue Corporation is an ophthalmic device company dedicated to working with eye care professionals and clinical researchers to lead the commercialization of new imaging modalities that improve diagnosis and therapy of ocular disease. Incorporated in December 2003 and located in Fremont California, Optovue was founded by pioneers of Optical Coherence Tomography to develop the next generation ophthalmic diagnosis instrument based on the Fourier-Domain OCT technology. The ultra-high speed high resolution FD-OCT provides physicians with advanced retina diagnostic capabilities that will have significant benefit for patients who have retina conditions such as macular degeneration, diabetic retinopathy, glaucoma, and other macular diseases.

Fortinet

Series D in 2003
Fortinet is a provider of network security appliances. Fortinet's portfolio of security gateways, subscription services, and complementary products delivers a high level of network, content, and application security for enterprises of all sizes, managed service providers, and telecommunications carriers, while reducing total cost of ownership and providing a flexible, scalable path for expansion. See an analyst interview of John Maddison, VP Marketing at Fortinet here: https://vimeo.com/129352269

Eureka Therapeutics

Series C in 2014
Eureka Therapeutics is a biotechnology company that focuses on immunotherapies for the treatment of cancer. The company's platform is a novel T-cell therapy construct that mimics the natural biology of T-cells to fight cancer. It utilizes a paradigm-changing technology platform to develop fully-human antibodies against intracellular cancer antigens. Eureka Therapeutics was founded in 2006 and is headquartered in Emeryville, California.

Autekbio

Series B in 2007
AutekBio, Inc. operates as a biopharmaceutical contract development and manufacturing company. It specializes in the production of therapeutic proteins and antibodies from mammalian cell culture. The company’s services include transient protein production services; cell line development services; upstream process development/downstream process development services; and non-GMP production services. In addition, its technology comprises vector and cell line, cell culture development, and disposable single-use bioreactor technologies. AutekBio, Inc. is based in Santa Clara, California with a manufacturing location in Beijing, China.

Flat Medical

Series A in 2017
Flat Medical Co., Ltd. designs, develops, and manufactures clinical safety solutions. The company offers EpiFaith syringe, an epidural space locating syringe which is equipped with visual indicator upon reaching the epidural space: EpiFaith CV, a visualized pressure indicating syringe which allows to prevent arterial cannulations. Flat Medical Co., Ltd. was founded in 2015 and is headquartered in Oakland, California.

Autekbio

Series A in 2007
AutekBio, Inc. operates as a biopharmaceutical contract development and manufacturing company. It specializes in the production of therapeutic proteins and antibodies from mammalian cell culture. The company’s services include transient protein production services; cell line development services; upstream process development/downstream process development services; and non-GMP production services. In addition, its technology comprises vector and cell line, cell culture development, and disposable single-use bioreactor technologies. AutekBio, Inc. is based in Santa Clara, California with a manufacturing location in Beijing, China.

Flat Medical

Private Placement in 2020
Flat Medical Co., Ltd. designs, develops, and manufactures clinical safety solutions. The company offers EpiFaith syringe, an epidural space locating syringe which is equipped with visual indicator upon reaching the epidural space: EpiFaith CV, a visualized pressure indicating syringe which allows to prevent arterial cannulations. Flat Medical Co., Ltd. was founded in 2015 and is headquartered in Oakland, California.

Qpixel Technology

Series B in 2006
Qpixel Technology operates as a fabless semiconductor company which provides video compression silicon and software solutions. It develops audio/video compression silicon solutions for digital consumer electronics devices, such as digital cameras and camcorders, set top boxes/PVRs/DVRs and remote monitoring devices, and IP video communications devices. The company's product suite includes standard and high definition codecs with on-chip audio DSP; and design kit, including boards, firmware, and design files for original equipment manufacturer time-to-production. Qpixel Technology, Inc. was founded in 2003 and is headquartered in Cupertino, California with engineering and sales offices in Taiwan and Japan.

RASILIENT SYSTEMS

Series A in 2003
RASILIENT Systems, Inc. provides video surveillance storage platforms and system software. It offers storage system technologies, including a storage appliance, which is a 2U/12 bay SBB based enclosure for video surveillance applications for system integrator and OEM customers. The company was incorporated in 2001 and is based in Sunnyvale, California with development centers in California, Shanghai, and Taipei.

Leopard Logic

Series A in 2001
Leopard Logic is a fabless semiconductor company that designs, develops, and provides embedded programmable logic solutions.

Optovue

Series A in 2004
Optovue Corporation is an ophthalmic device company dedicated to working with eye care professionals and clinical researchers to lead the commercialization of new imaging modalities that improve diagnosis and therapy of ocular disease. Incorporated in December 2003 and located in Fremont California, Optovue was founded by pioneers of Optical Coherence Tomography to develop the next generation ophthalmic diagnosis instrument based on the Fourier-Domain OCT technology. The ultra-high speed high resolution FD-OCT provides physicians with advanced retina diagnostic capabilities that will have significant benefit for patients who have retina conditions such as macular degeneration, diabetic retinopathy, glaucoma, and other macular diseases.

Eureka Therapeutics

Series B in 2008
Eureka Therapeutics is a biotechnology company that focuses on immunotherapies for the treatment of cancer. The company's platform is a novel T-cell therapy construct that mimics the natural biology of T-cells to fight cancer. It utilizes a paradigm-changing technology platform to develop fully-human antibodies against intracellular cancer antigens. Eureka Therapeutics was founded in 2006 and is headquartered in Emeryville, California.

Luxnet

Venture Round in 2001
LuxNet Corporation designs, develops, and manufactures optical semiconductor devices and packaged optical components in Taiwan. The company provides laser and photo diode chips, transmitters, receivers, and optical sub-assemblies. Its products are used in high speed voice video and data communications for networking, storage, and cable TV, as well as optical communication applications. The company was founded in 1999 and is headquartered in Taoyuan City, Taiwan.